- Academic Programs
- Students and Admissions
- Alumni and Giving
Woster research an awardee in Sickle Cell Disease/Advancing Cures funding; fast-track research focused on developing a new gene-modifying sickle cell disease treatment at MUSC could lead to human clinical trials in as few as three years.
The College of Pharmacy at the Medical University of South Carolina provides a premier pharmacy education leveraging the innovative inter-professional learning opportunities offered at South Carolina’s only comprehensive academic health center with a full range of programs in the biomedical sciences.
South Carolina pharmacists and student pharmacists at the American Society of Health-System Pharmacists Midyear Clinical Meeting can network and socialize at the South Carolina Pharmacy Reception on Monday, December 4, 2017 at the Funky Monkey Bistro & Bar in Orlando.
The 2017 White Coat Ceremony featured as keynote speaker Nancy G. Mikell, who was also presented with the Honorary Alumnus of the Year Award. Mikell's address was the highlight of a week of 2017 Orientation activities capped by the ceremony at Baruch Auditorium August 17.
Faculty nationally recognized for achievement in both teaching and practice provide interprofessional education and training in patient care, critical thinking and professional leadership.
The MUSC College of Pharmacy has teamed up with the USC College of Pharmacy to help provide accredited professional educational activities for pharmacists and pharmacy technicians to enhance performance, core competencies and to promote the value of pharmacy within the healthcare team. Education is provided through live conferences, live workshops, home study programs and on-line activities. The CE office also works with other affiliates, agencies and healthcare disciplines to co-sponsor educational activities. We will collaborate with your organization to develop and deliver customized educational programing to meet your specific organizational learning gaps and objectives.
Fast-track research focused on developing a new gene-modifying sickle cell disease treatment at the Medical University of South Carolina could lead to human clinical trials in as few as three years....Read more...